Insulin Pumps: Diabetes Management on Earth and in Space
Insulin pumps deliver continuous subcutaneous insulin infusion (CSII), mimicking physiological basal/bolus secretion. They are transformative for type 1 diabetes — and have flown in space since 1985.
Terrestrial Use
- Basal rates programmable by time of day.
- Bolus calculator (carb ratio, insulin sensitivity, active insulin time).
- CGM integration (hybrid closed loop / automated insulin delivery).
- Improves HbA1c, reduces hypoglycemia, enhances quality of life.
Spaceflight Adaptation
- First use: 1985 (STS-51-F, not 1975 — Charles Bassett died in 1966). Jay Apt (STS-37, 1991) and others used pumps on Shuttle.
- Microgravity effects: Fluid shift → altered insulin absorption; pump provides stable delivery vs. injections.
- Challenges: Thermal control (insulin denatures >30°C); radiation hardening; bubble formation in tubing; limited resupply; crew training for pump management.
Current Status
Pumps are standard for astronauts with diabetes. Artemis and future missions will require closed-loop systems with enhanced reliability and autonomy.
Space use validates pump robustness — benefits Earth patients through technology transfer.
Diabetes - Related Articles
- Understanding Diabetes Side Effects: Management & Complications
- Exercise for Children with Diabetes: Benefits & Guidelines
- A Brief History of Blood Sugar Testing: From Early Days to Modern Meters
- Epsom Salt Foot Soak: Optimal Time, Benefits & Precautions
- Pre-Blood Glucose Testing: Nursing Considerations for Accurate Results
- Type 1 vs. Type 2 Diabetes: Distinct Causes, No Shared "Stages"
- Diabetes-Friendly Foods: A Comprehensive Guide for Healthy Living
